of lives saved. the future of global pharmaceuticals lies in biological medicines and cell products. the institute of biophysics of cell engineerings research, the results which help to resist difficult -to-treat diseases. at least twenty cellular products have been developed at the meeting in the work of the virology center. the coronavirus pandemic has pushed us to intensify in this direction, but specialists do not intend to rely only on the covid vaccine, we have experience, with the introduction of a new plant there will be enough production capacity for the production of drugs, these are not only those vaccines that are widely used and are widely included in our vaccination calendar, belarusian, but it is also possible that vaccines that will go to export, that is, for diseases that are more relevant for countries, say africa, say asia or south america, all major developments can be expected as early as next year, medicine in general. this is the case when it’s better, even if it’s not useful, but it’s good that we have our own medications - this is a guarantor of safety, the academ pharm enterprise appeared 14 years ago, to

of lives saved. the future of global pharmaceuticals lies in biological medicines and cell products. the institute of biophysics of cellular engineering, the results of which help combat difficult -to-treat diseases. at least twenty cell products have been developed at the institution since the summer in the work of the virology center. the coronavirus pandemic pushed us to strengthen in this direction, but it is stopping. only on the covid vaccine, experts do not we intend, we have experience, with the introduction of a new plant, there will be enough production capacity to produce drugs, these are not only those vaccines that are widely used and included in our belarusian vaccination calendar, but also possibly vaccines that will be exported, that is, for the disease , which are more relevant for countries, say africa, say asia or south america, all the main developments can be expected next year, in general medicine is the one... when it’s better if it’s not useful, but it’s good that we have our own medications, this guarantor of security. the academ pharm enterprise appeared 14 years ago, today it is among the best manufacturers